HEADER TRANSFERASE/TRANSFERASE INHIBITOR 14-FEB-14 4OTR TITLE CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6-CYCLOPROPYL-2- TITLE 2 [3-[5-[[5-(4-ETHYLPIPERAZIN-1-YL)-2-PYRIDYL]AMINO]-1-METHYL-6-OXO-3- TITLE 3 PYRIDYL]-2-(HYDROXYMETHYL)PHENYL]-8-FLUORO-ISOQUINOLIN-1-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 378-659; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE, ATK, B-CELL PROGENITOR COMPND 6 KINASE, BPK, BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.KUGLSTATTER,A.WONG REVDAT 4 20-SEP-23 4OTR 1 REMARK SEQADV REVDAT 3 17-JUL-19 4OTR 1 REMARK REVDAT 2 21-JAN-15 4OTR 1 JRNL REVDAT 1 14-MAY-14 4OTR 0 JRNL AUTH Y.LOU,X.HAN,A.KUGLSTATTER,R.K.KONDRU,Z.K.SWEENEY,M.SOTH, JRNL AUTH 2 J.MCINTOSH,R.LITMAN,J.SUH,B.KOCER,D.DAVIS,J.PARK, JRNL AUTH 3 S.FRAUCHIGER,N.DEWDNEY,H.ZECIC,J.P.TAYGERLY,K.SARMA,J.HONG, JRNL AUTH 4 R.J.HILL,T.GABRIEL,D.M.GOLDSTEIN,T.D.OWENS JRNL TITL STRUCTURE-BASED DRUG DESIGN OF RN486, A POTENT AND SELECTIVE JRNL TITL 2 BRUTON'S TYROSINE KINASE (BTK) INHIBITOR, FOR THE TREATMENT JRNL TITL 3 OF RHEUMATOID ARTHRITIS. JRNL REF J.MED.CHEM. V. 58 512 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 24712864 JRNL DOI 10.1021/JM500305P REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0048 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 3 NUMBER OF REFLECTIONS : 19041 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1035 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 745 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 48.69 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE SET COUNT : 38 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2139 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 200 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.62000 REMARK 3 B22 (A**2) : 0.39000 REMARK 3 B33 (A**2) : -2.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.185 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.166 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.137 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.429 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2247 ; 0.016 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3035 ; 1.635 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 262 ; 6.257 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 104 ;35.408 ;24.135 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 401 ;13.130 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;15.881 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 319 ; 0.110 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1710 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1051 ; 1.217 ; 1.715 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1312 ; 1.817 ; 2.566 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1196 ; 2.451 ; 1.984 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3697 ; 5.799 ;15.604 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 396 A 407 REMARK 3 RESIDUE RANGE : A 453 A 476 REMARK 3 RESIDUE RANGE : A 418 A 436 REMARK 3 ORIGIN FOR THE GROUP (A): 18.9702 -1.8791 7.8514 REMARK 3 T TENSOR REMARK 3 T11: 0.0775 T22: 0.0387 REMARK 3 T33: 0.0624 T12: -0.0172 REMARK 3 T13: 0.0175 T23: 0.0028 REMARK 3 L TENSOR REMARK 3 L11: 0.0764 L22: 4.0198 REMARK 3 L33: 0.5776 L12: 0.2743 REMARK 3 L13: 0.1674 L23: -0.1554 REMARK 3 S TENSOR REMARK 3 S11: 0.0137 S12: 0.0063 S13: -0.0418 REMARK 3 S21: -0.0979 S22: 0.1239 S23: 0.0968 REMARK 3 S31: 0.0820 S32: 0.0076 S33: -0.1376 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 477 A 514 REMARK 3 RESIDUE RANGE : A 559 A 658 REMARK 3 ORIGIN FOR THE GROUP (A): 19.0433 27.2427 2.7384 REMARK 3 T TENSOR REMARK 3 T11: 0.0371 T22: 0.0386 REMARK 3 T33: 0.0167 T12: -0.0028 REMARK 3 T13: 0.0013 T23: 0.0008 REMARK 3 L TENSOR REMARK 3 L11: 0.4321 L22: 0.5846 REMARK 3 L33: 1.2508 L12: -0.0323 REMARK 3 L13: -0.1758 L23: -0.0341 REMARK 3 S TENSOR REMARK 3 S11: 0.0065 S12: 0.0090 S13: 0.0575 REMARK 3 S21: 0.0076 S22: 0.0057 S23: 0.0223 REMARK 3 S31: -0.0316 S32: -0.0290 S33: -0.0122 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 437 A 452 REMARK 3 ORIGIN FOR THE GROUP (A): 16.4440 5.2956 19.7792 REMARK 3 T TENSOR REMARK 3 T11: 0.0672 T22: 0.0283 REMARK 3 T33: 0.0546 T12: -0.0308 REMARK 3 T13: 0.0057 T23: 0.0090 REMARK 3 L TENSOR REMARK 3 L11: 11.5240 L22: 3.2619 REMARK 3 L33: 3.3997 L12: -3.7798 REMARK 3 L13: 3.9411 L23: -1.8550 REMARK 3 S TENSOR REMARK 3 S11: 0.1365 S12: -0.2445 S13: -0.6308 REMARK 3 S21: 0.1140 S22: 0.0257 S23: 0.0725 REMARK 3 S31: 0.1096 S32: -0.2531 S33: -0.1622 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 408 A 417 REMARK 3 ORIGIN FOR THE GROUP (A): 28.6323 4.3649 7.3294 REMARK 3 T TENSOR REMARK 3 T11: 0.0265 T22: 0.3877 REMARK 3 T33: 0.0931 T12: 0.0582 REMARK 3 T13: 0.0122 T23: -0.1221 REMARK 3 L TENSOR REMARK 3 L11: 7.5120 L22: 4.1278 REMARK 3 L33: 2.7737 L12: -0.5281 REMARK 3 L13: -2.3622 L23: -2.7049 REMARK 3 S TENSOR REMARK 3 S11: 0.0206 S12: -0.3044 S13: 0.2918 REMARK 3 S21: -0.2925 S22: -0.1796 S23: -0.4005 REMARK 3 S31: 0.2110 S32: 0.3208 S33: 0.1590 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 515 A 558 REMARK 3 ORIGIN FOR THE GROUP (A): 21.5506 14.9365 10.3753 REMARK 3 T TENSOR REMARK 3 T11: 0.0520 T22: 0.0424 REMARK 3 T33: 0.0041 T12: -0.0118 REMARK 3 T13: 0.0013 T23: 0.0036 REMARK 3 L TENSOR REMARK 3 L11: 0.9706 L22: 0.9239 REMARK 3 L33: 1.8467 L12: 0.3127 REMARK 3 L13: 0.4868 L23: -0.6605 REMARK 3 S TENSOR REMARK 3 S11: -0.0310 S12: -0.0451 S13: -0.0196 REMARK 3 S21: 0.0140 S22: -0.0284 S23: -0.0358 REMARK 3 S31: 0.0728 S32: 0.0262 S33: 0.0594 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4OTR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-FEB-14. REMARK 100 THE DEPOSITION ID IS D_1000084937. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : LIQUID NITROGEN COOLED DUAL REMARK 200 CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20058 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 42.720 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10300 REMARK 200 FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 48.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.39900 REMARK 200 FOR SHELL : 1.860 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 3PIX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 33% PEG3350, 0.1 M HEPES, PH 8.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.76850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.22900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.76850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.22900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 377 REMARK 465 SER A 378 REMARK 465 GLN A 379 REMARK 465 GLN A 380 REMARK 465 ASN A 381 REMARK 465 LYS A 382 REMARK 465 ASN A 383 REMARK 465 ALA A 384 REMARK 465 PRO A 385 REMARK 465 SER A 386 REMARK 465 THR A 387 REMARK 465 ALA A 388 REMARK 465 GLY A 389 REMARK 465 LEU A 390 REMARK 465 GLY A 391 REMARK 465 TYR A 392 REMARK 465 GLY A 393 REMARK 465 SER A 394 REMARK 465 TRP A 395 REMARK 465 SER A 659 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 843 O HOH A 929 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 802 O HOH A 917 3545 1.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 481 CB CYS A 481 SG -0.109 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 424 -51.88 -137.15 REMARK 500 LYS A 466 42.42 -98.77 REMARK 500 ARG A 520 -10.65 77.44 REMARK 500 ASP A 521 48.49 -141.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2V3 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 703 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4OT5 RELATED DB: PDB REMARK 900 RELATED ID: 4OT6 RELATED DB: PDB REMARK 900 RELATED ID: 4OTQ RELATED DB: PDB DBREF 4OTR A 378 659 UNP Q06187 BTK_HUMAN 378 659 SEQADV 4OTR GLY A 377 UNP Q06187 EXPRESSION TAG SEQADV 4OTR ALA A 489 UNP Q06187 MET 489 ENGINEERED MUTATION SEQADV 4OTR ALA A 492 UNP Q06187 ARG 492 ENGINEERED MUTATION SEQADV 4OTR ALA A 624 UNP Q06187 GLU 624 ENGINEERED MUTATION SEQADV 4OTR ALA A 625 UNP Q06187 LYS 625 ENGINEERED MUTATION SEQRES 1 A 283 GLY SER GLN GLN ASN LYS ASN ALA PRO SER THR ALA GLY SEQRES 2 A 283 LEU GLY TYR GLY SER TRP GLU ILE ASP PRO LYS ASP LEU SEQRES 3 A 283 THR PHE LEU LYS GLU LEU GLY THR GLY GLN PHE GLY VAL SEQRES 4 A 283 VAL LYS TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA SEQRES 5 A 283 ILE LYS MET ILE LYS GLU GLY SER MET SER GLU ASP GLU SEQRES 6 A 283 PHE ILE GLU GLU ALA LYS VAL MET MET ASN LEU SER HIS SEQRES 7 A 283 GLU LYS LEU VAL GLN LEU TYR GLY VAL CYS THR LYS GLN SEQRES 8 A 283 ARG PRO ILE PHE ILE ILE THR GLU TYR MET ALA ASN GLY SEQRES 9 A 283 CYS LEU LEU ASN TYR LEU ARG GLU ALA ARG HIS ALA PHE SEQRES 10 A 283 GLN THR GLN GLN LEU LEU GLU MET CYS LYS ASP VAL CYS SEQRES 11 A 283 GLU ALA MET GLU TYR LEU GLU SER LYS GLN PHE LEU HIS SEQRES 12 A 283 ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN SEQRES 13 A 283 GLY VAL VAL LYS VAL SER ASP PHE GLY LEU SER ARG TYR SEQRES 14 A 283 VAL LEU ASP ASP GLU TYR THR SER SER VAL GLY SER LYS SEQRES 15 A 283 PHE PRO VAL ARG TRP SER PRO PRO GLU VAL LEU MET TYR SEQRES 16 A 283 SER LYS PHE SER SER LYS SER ASP ILE TRP ALA PHE GLY SEQRES 17 A 283 VAL LEU MET TRP GLU ILE TYR SER LEU GLY LYS MET PRO SEQRES 18 A 283 TYR GLU ARG PHE THR ASN SER GLU THR ALA GLU HIS ILE SEQRES 19 A 283 ALA GLN GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SER SEQRES 20 A 283 ALA ALA VAL TYR THR ILE MET TYR SER CYS TRP HIS GLU SEQRES 21 A 283 LYS ALA ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SER SEQRES 22 A 283 ASN ILE LEU ASP VAL MET ASP GLU GLU SER HET 2V3 A 701 46 HET DMS A 702 4 HET DMS A 703 4 HETNAM 2V3 6-CYCLOPROPYL-2-[3-(5-{[5-(4-ETHYLPIPERAZIN-1-YL) HETNAM 2 2V3 PYRIDIN-2-YL]AMINO}-1-METHYL-6-OXO-1,6-DIHYDROPYRIDIN- HETNAM 3 2V3 3-YL)-2-(HYDROXYMETHYL)PHENYL]-8-FLUOROISOQUINOLIN- HETNAM 4 2V3 1(2H)-ONE HETNAM DMS DIMETHYL SULFOXIDE FORMUL 2 2V3 C36 H37 F N6 O3 FORMUL 3 DMS 2(C2 H6 O S) FORMUL 5 HOH *200(H2 O) HELIX 1 1 ASP A 398 LYS A 400 5 3 HELIX 2 2 SER A 438 ASN A 451 1 14 HELIX 3 3 LEU A 482 GLU A 488 1 7 HELIX 4 4 ALA A 489 ALA A 492 5 4 HELIX 5 5 GLN A 494 LYS A 515 1 22 HELIX 6 6 ALA A 523 ARG A 525 5 3 HELIX 7 7 GLY A 541 VAL A 546 5 6 HELIX 8 8 ASP A 548 SER A 553 1 6 HELIX 9 9 PRO A 560 SER A 564 5 5 HELIX 10 10 PRO A 565 SER A 572 1 8 HELIX 11 11 SER A 575 SER A 592 1 18 HELIX 12 12 THR A 602 GLN A 612 1 11 HELIX 13 13 SER A 623 CYS A 633 1 11 HELIX 14 14 LYS A 637 ARG A 641 5 5 HELIX 15 15 THR A 643 GLU A 658 1 16 SHEET 1 A 5 LEU A 402 GLY A 411 0 SHEET 2 A 5 GLY A 414 TRP A 421 -1 O VAL A 416 N LEU A 408 SHEET 3 A 5 TYR A 425 MET A 431 -1 O ILE A 429 N LYS A 417 SHEET 4 A 5 PHE A 471 GLU A 475 -1 O ILE A 472 N LYS A 430 SHEET 5 A 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 B 3 GLY A 480 CYS A 481 0 SHEET 2 B 3 CYS A 527 VAL A 529 -1 O VAL A 529 N GLY A 480 SHEET 3 B 3 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 0.36 SITE 1 AC1 22 LEU A 408 GLY A 409 THR A 410 GLY A 411 SITE 2 AC1 22 PHE A 413 VAL A 416 ALA A 428 LYS A 430 SITE 3 AC1 22 THR A 474 GLU A 475 MET A 477 ALA A 478 SITE 4 AC1 22 GLY A 480 ASN A 526 LEU A 528 SER A 538 SITE 5 AC1 22 ASP A 539 SER A 543 VAL A 546 TYR A 551 SITE 6 AC1 22 HOH A 807 HOH A 972 SITE 1 AC2 5 TYR A 551 THR A 552 PHE A 559 PHE A 574 SITE 2 AC2 5 HOH A 808 SITE 1 AC3 6 ARG A 520 TRP A 563 SER A 564 SER A 578 SITE 2 AC3 6 HOH A 804 HOH A 815 CRYST1 71.537 106.458 38.265 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013979 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009393 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026134 0.00000